Literature DB >> 19022494

A desensitization protocol for the mAb cetuximab.

Maya R Jerath, Mildred Kwan, Mily Kannarkat, Beloo Mirakhur, Lisa Carey, John Valgus, Thomas A E Platts-Mills, Teresa K Tarrant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19022494     DOI： 10.1016/j.jaci.2008.09.046

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  2nd Charles Richet et Jules Héricourt workshop: therapeutic antibodies and anaphylaxis; May 31-June 1, 2011, Tours, France.

Authors:  Arnaud Daguet; Hervé Watier
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

2.  Allergenicity of carbohydrates and their role in anaphylactic events.

Authors:  Scott P Commins; Thomas A E Platts-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

3.  Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis.

Authors:  Delphine Mariotte; Benoît Dupont; Radj Gervais; Marie-Pierre Galais; Dominique Laroche; Aurore Tranchant; Elisabeth Comby; Karine Bouhier-Leporrier; Jean-Marie Reimund; Brigitte Le Mauff
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

Review 4.  Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant.

Authors:  Scott P Commins; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2009-10       Impact factor: 10.793

Review 5.  Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.

Authors:  Jamie L Waldron; Stephen A Schworer; Mildred Kwan
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-28       Impact factor: 8.667

Review 6.  Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat.

Authors:  Scott P Commins; Maya R Jerath; Kelly Cox; Loren D Erickson; Thomas Platts-Mills
Journal:  Allergol Int       Date:  2015-11-21       Impact factor: 5.836

7.  Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection.

Authors:  Kyung Hee Park; Jongsun Lee; Seung Hoon Beom; Sang Joon Shin; Joong Bae Ahn; Sung-Ryeol Kim; Jae-Hyun Lee; Jung-Won Park
Journal:  World Allergy Organ J       Date:  2021-06-23       Impact factor: 4.084
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.